Asymmetric dimethylarginine levels in allergic rhinitis and nasal polyposis

Asymmetric dimethylarginine (ADMA) is the major endogenous inhibitor of nitric oxide synthase. We aimed to investigate the ADMA levels in allergic rhinitis (AR) and nasal polyposis (NP). Materials and methods: A total of 29 AR patients, 21 NP patients, and 30 healthy subjects to be used as a control group were enrolled in the study. ADMA was measured in the AR, NP, and control groups with enzyme-linked immunosorbent assay. Any patients or control subjects with coronary artery disease, renal failure, diabetes mellitus, or hypertension were excluded from the study. Results: The mean ADMA serum concentration was 0.52 ± 0.08 µmol/L in the AR group, 0.62 ± 0.10 µmol/L in the NP group, and 0.67 ± 0.09 µmol/L in the control group. The ADMA serum concentration in the AR group was significantly lower than in the control group (P < 0.001). Considered together, the NP and AR groups had ADMA levels that were significantly lower than in the control group (P < 0.001). Conclusion: In the present study, lower ADMA levels were found in the AR and NP groups.

Anahtar Kelimeler:

Key words: Asymmetric dimethylarginine, allergic rhinitis, nasal polyposis

Asymmetric dimethylarginine levels in allergic rhinitis and nasal polyposis

Keywords:

Key words: Asymmetric dimethylarginine, allergic rhinitis, nasal polyposis,

PDF

___

Mucci T, Govindaraj S, Tversky J. Allergic rhinitis. Mt Sinai J Med 2011; 78: 634–44.
Naclerio RM. Allergic rhinitis. N Engl J Med 1991; 325: 860–9.
Bernstein JM. Update on the molecular biology of nasal polyposis. Otolaryngol Clin North Am 2005; 38: 1243–55.
Drake-Lee A. The pathogenesis of nasal polyps. In: Settipane G, Lund VJ, Bernstein JM, Tos M, editors. Nasal polyps: epidemiology, pathogenesis and treatment. Providence, RI, USA: Oceanside Publications; 1997. p.57–64.
Fokkens W, Lund V, Mullol J. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 2007: 1–1
Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109–42.
Kaplan İ, Aydın Y, Bilen Y, Genç F, Keleş MS, Eroğlu A. The evaluation of plasma arginine, arginase, and nitric oxide levels in patients with esophageal cancer. Turk J Med Sci 2012; 42: 403–409.
Arnal JF, Didier A, Rami J, M’Rini C, Charlet JP, Serrano E et al. Nasal nitric oxide is increased in allergic rhinitis. Clin Exp Allergy 1997; 27: 358–62.
Silkoff PE, Chatkin J, Qian W, Chakravorty S, Gutierrez C, Furlott H et al. Nasal nitric oxide: a comparison of measurement techniques. Am J Rhinol 1999; 13: 169–78.
Vallance P, Leone A, Calver A, Collier J, Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 1992; 20: S60–2.
Klein E, Weigel J, Buford MC, Holian A, Wells SM. Asymmetric dimethylarginine potentiates lung inflammation in a mouse model of allergic asthma. Am J Physiol Lung Cell Mol Physiol 2010; 299: L816–25.
Wells SM, Buford MC, Migliaccio CT, Holian A. Elevated asymmetric dimethylarginine alters lung function and induces collagen deposition in mice. J Respir Cell Mol Biol 2009; 40: 179–88.
Scott JA, North ML, Rafii M, Huang HL, Pencharz P, Subbarao P et al. Asymmetric dimethylarginine is increased in asthma. Am J Resp Crit Care 2011; 184: 779–85.
Alcelik A, Ozhan H, Alcelik AG, Yalcin S, Aydin Y. Asymmetric dimethyl arginine level as a cardiovascular risk factor in patients with hyperthyroidism. Acta Endocrinol (Buc) 2012; 8: 27–
Sibal L, Agarwal SC, Home PD, Boger RH. The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease. Curr Cardiol Rev 2010; 6: 82–90.
Kökçam İ, Dertlioğlu SB. The levels of nitric oxide and metabolites in Behçet’s disease. Turk J Med Sci 2011; 41: 587–94.
Bakkeheim E, Mowinckel P, Carlsen KH, Burney P, Carlsen KC. Altered oxidative state in schoolchildren with asthma and allergic rhinitis. Pediatr Allergy Immunol 2011; 22: 178–85.
Jiao J, Zhang W, Meng N, Wang H, Zhang L. Changes of oxidative stress in peripheral serum of patients with allergic rhinitis. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2010; 45: 455–8 (in Chinese with English abstract).
Kawamoto H, Takeno S, Yajin K. Increased expression of inducible nitric oxide synthase in nasal epithelial cells in patients with allergic rhinitis. Laryngoscope 1999; 109: 2015–20.
Oh SJ, Min YG, Kim JW, Lee SJ, Jarin PR. Expression of nitric oxide synthases in nasal mucosa from a mouse model of allergic rhinitis. Ann Otolo Rhinol Laryngol 2003; 112: 899–903.
Chiba Y, Matsuo K, Sakai H, Abe K, Misawa M. Increased expression of inducible nitric oxide synthase in nasal mucosae of guinea pigs with induced allergic rhinitis. Am J Rhinol 2006; 20: 336–41.
Li Y, Wang Y, Zhang Q. Expression of cell adhesion molecule and nitric oxide synthase in nasal mucosa in allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2006; 20: 315–8 (in Chinese with English abstract).
Ciprandi G, Tosca MA, Capasso M. Exhaled nitric oxide in children with allergic rhinitis and/or asthma: a relationship with bronchial hyperreactivity. J Asthma 2010; 47: 1142–7.
Xu F, Zou Z, Yan S, Li F, Kan H, Norback D et al. Fractional exhaled nitric oxide in relation to asthma, allergic rhinitis, and atopic dermatitis in Chinese children. J Asthma 2011; 48: 1001–6.
Ciprandi G, Tosca M, Fuchs D. Nitric oxide metabolites in allergic rhinitis: The effect of pollen allergen exposure. Allergol Immunopathol (Madr) 2011; 39: 326–9.
Jeanson L, Kelly M, Coste A, Guerrera IC, Fritsch J, NguyenKhoa T et al. Oxidative stress induces unfolding protein response and inflammation in nasal polyposis. Allergy 2012; 67: 403–12.
Veyseller B, Aksoy E, Ertaş B, Keskin M, Ozturan O, Yildirim YS et al. A new oxidative stress marker in patients with nasal polyposis: advanced oxidation protein products (AOPP). B-ENT 2010; 6: 105–9.
Escobar P, Marquez FJ, Carrasco C, Alonso-Orgaz S, Fortes J, Cenjor C et al. Endothelial nitric oxide synthase/soluble guanylate cyclase system in human nasal polyps. Eur Arch Otorhinolaryngol 2005; 262: 512–6.
Yuksel H, Kirmaz C, Yilmaz O, Pinar E, Vatansever S, Degirmenci PB et al. Nasal mucosal expression of nitric oxide synthases in patients with allergic rhinitis and its relation to asthma. Ann Allergy Asthma Immunol 2008; 100: 12–6.
Yoshimura T, Moon TC, St Laurent CD, Puttagunta L, Chung K, Wright E et al. Expression of nitric oxide synthases in leukocytes in nasal polyps. Ann Allergy Asthma Immunol 2012; 108: 172–7.